Lonsurf
Active Ingredient(s): Trifluridine + TipiracilFDA Approved: * September 22, 2015
Pharm Company: * TAIHO ONCOLOGY INC
Category: Cancer
Trifluridine/tipiracil, sold under the brand name Lonsurf, is a fixed-dose combination medication that is used as a third- or fourth-line treatment of metastatic colorectal cancer or gastric cancer, after chemotherapy and targeted therapeutics have failed.[2][3] It is a combination of two active pharmaceutical ingredients: trifluridine, a nucleoside analog, and tipiracil, a thymidine phosphorylase inhibitor.[2][3] Tipiracil prev... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.